Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT

AIMS: Regenerative therapies have evolved as a promising new option in the treatment of post-infarction heart failure. A major limitation of intracoronary application of autologous bone marrow-derived mononuclear cells (BM-MNCs) is that homing of the applied cells is profoundly reduced in patients w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Assmus, Birgit, Alakmeh, Samer, De Rosa, Salvatore, Bönig, Halvard, Hermann, Eva, Levy, Wayne C., Dimmeler, Stefanie, Zeiher, Andreas M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841212/
https://ncbi.nlm.nih.gov/pubmed/26516172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv559
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars